KRONOS® AIR DISINFECTION TECHNOLOGY MANUFACTURER RECEIVES FDA 510(K) CLASS II MEDICAL DEVICE CLEARANCE FOR THE DESTRUCTION OF VIRUSES, BACTERIA, AND ALLERGENS.

Parkersburg, WV, Jan. 10, 2023 (GLOBE NEWSWIRE) — Parkersburg, WV January 10, 2023 /Globenewswire/ KRONOS ADVANCED TECHNOLOGIES, INC. (OTC MARKETS: KNOS) (“KNOS” or the “Company”), innovation-driven product development and creator of patented Kronos® CORE air disinfection technology inside its advanced smart air purification devices, announced today that the U.S. Food and Drug Administration (FDA) has recently granted 510(k) clearance, classifying it as a Class II Medical Device. The FDA clearance was provided to the product manufacturer after a detailed review of the patented Model 5 device, which utilizes patented High Voltage Field air disinfection technology and is proven to eliminate 99.9% of harmful airborne particles, including allergens, bacteria, fungi, and viruses, like COVID-19. FDA Clearance which means our air purifiers can be deployed in hospitals and home health-care settings to clear the air of infected bioaerosol droplets , in addition, our products comply with all CARB regulations related to air cleaners for sale in California, and the Company’s manufacturer is registered with the State of California CARB.

Read more at globenewswire.com

Related news for (KNOS)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.